Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.

Mease, Philip J

Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data. [electronic resource] - The Annals of pharmacotherapy Feb 2011 - 179-88 p. digital

Publication Type: Journal Article

1542-6270

10.1345/aph.1P391 doi


Adrenergic Uptake Inhibitors--adverse effects
Adult
Amitriptyline--adverse effects
Antidepressive Agents--adverse effects
Cardiovascular Diseases--chemically induced
Cyclopropanes--adverse effects
Female
Heart Failure--chemically induced
Humans
Male
Middle Aged
Milnacipran
Myocardial Infarction--chemically induced
Retrospective Studies
Risk
Selective Serotonin Reuptake Inhibitors--adverse effects
Stroke--chemically induced
United States
Venlafaxine Hydrochloride--therapeutic use